Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia

Frontiers in Medicine

Clara Franco-Jarava¹  Manuel Hernández-González¹  Marcos Pérez-Carrasco²  Adolf Ruiz-Sanmartin²  Clara Palmada²  ErikaPaola Plata-Menchaca²  Luis Chiscano-Camón³  Ricard Ferrer³  Juan Carlos Ruiz-Rodríguez³ 

[1] Department of Immunology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain;Department of Intensive Care, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain;Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain;Department of Intensive Care, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain;Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain;Departament de Medicina, Universitat Autonoma de Barcelona, Barcelona, Spain;

关键词: SARS-CoV-2 pneumonia;    hemoadsorption;    acute respiratory distress syndrome (ARDS);    hypercytokinemia;    COVID-19;   

DOI  :  10.3389/fmed.2021.779038

来源: Frontiers

【 授权许可】

CC BY